Varicose Veins Treatment Market Size & Growth Forecast 2027–2036, By Segments (Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Varicose Veins Treatment Market size was around USD 1.6 billion in 2026 and is slated to grow at a 6.08% CAGR from 2027 to 2036, crossing USD 2.89 billion by 2036. The industry revenue for 2027 is calculated at USD 1.68 billion.
Get more details on this report
Request Free Sample ReportVaricose Veins Treatment Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 47.28% market share in 2026, supported by high procedural volumes, broad access to minimally invasive therapies, and efficient clinical referral pathways.
- Asia Pacific is projected to expand at a 7.35% CAGR, driven by improving access to vascular care, earlier diagnosis, greater availability of minimally invasive treatments, and expanding outpatient services.
Segment Momentum
- It holds 66.45% share due to widespread clinical familiarity, routine outpatient use, and established effectiveness across a broad range of visible vein conditions.
- It is growing fastest due to increasing preference for minimally invasive procedures that improve efficiency, enable same-day treatment, and align with modern outpatient care models.
Market Expansion Drivers
- Rising sedentary lifestyles and aging population increasing prevalence of venous disorders.
- Growing adoption of minimally invasive endovenous and laser treatment procedures.
- Advancements in outpatient vascular treatment centers improving accessibility and recovery outcomes.
Leading Market Participants
- Prominent players in the varicose veins treatment market include Medtronic plc (Ireland), AngioDynamics, Inc. (United States), Lumenis Be Ltd. (Israel), Alma Lasers Ltd. (Israel), Sciton, Inc. (United States), Quanta System S.p.A. (Italy), Dornier MedTech GmbH (Germany), intros Medical Laser GmbH (Germany), Theraclion SA (France), Biolitec AG (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.6 billion
- 2027 Estimated Market Size: USD 1.68 billion.
- Projected Market Size: USD 2.89 billion by 2036
- Growth Forecast: 6.08% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Injection Sclerotherapy (Type) | Hospitals (End-use)
- Emerging Opportunity Segment: Endovenous Ablation (Type) | Ambulatory Surgical Centers (End-use)
Market Growth Drivers and Industry Trends
Rising sedentary lifestyles and aging population increasing prevalence of venous disorders
The varicose veins treatment market is being supported by the increasing prevalence of venous disorders associated with sedentary lifestyles and population aging. Prolonged periods of inactivity can contribute to impaired venous circulation, while age-related changes increase susceptibility to vein-related conditions. This combination is expanding the pool of patients seeking diagnosis and treatment, strengthening demand for therapeutic interventions across vascular care settings.
Growing adoption of minimally invasive endovenous and laser treatment procedures
Growing acceptance of minimally invasive procedures is reshaping treatment preferences in the varicose veins treatment market, particularly as patients and providers favor interventions that reduce procedural burden. Endovenous and laser techniques offer alternatives to more invasive approaches, supporting greater use of procedure-based treatments where improved convenience and recovery considerations influence treatment decisions.
Advancements in outpatient vascular treatment centers improving accessibility and recovery outcomes
Advancements in outpatient vascular treatment centers are improving access to varicose vein care by enabling procedures to be performed in settings designed around efficient treatment and recovery. For the varicose veins treatment market, broader availability of specialized outpatient services can make vascular interventions more convenient for patients while supporting streamlined care pathways and recovery management.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising sedentary lifestyles and aging population increasing prevalence of venous disorders | 2.20% | Moderate | North America, Europe, Asia Pacific | High | Near Term |
| Growing adoption of minimally invasive endovenous and laser treatment procedures | 2.40% | High | North America, Europe | High | Near Term |
| Advancements in outpatient vascular treatment centers improving accessibility and recovery outcomes | 1.80% | Moderate | North America, Europe, Middle East & Africa | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the varicose veins treatment market in 2026, accounting for a 47.28% share, supported by advanced healthcare infrastructure, high awareness of vascular disorders, and strong access to specialized diagnostic and treatment services. The region benefits from established adoption of minimally invasive procedures, growing preference for outpatient interventions, and continued improvements in imaging and treatment technologies. An aging population and increasing attention to vascular health are also strengthening demand for effective management of chronic venous conditions. In addition, favorable healthcare spending patterns and the availability of specialized clinical expertise are supporting the broader adoption of both procedural and non-procedural treatment approaches.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing regional market, driven by expanding healthcare infrastructure, improving access to specialized vascular care, and rising awareness of varicose vein treatment options. Increasing urbanization, changing lifestyles, and a growing population requiring medical attention are contributing to greater recognition and diagnosis of venous disorders. Investments in hospitals and specialty healthcare facilities are improving the availability of advanced treatment technologies, while increasing medical tourism and broader healthcare coverage in several economies are supporting treatment accessibility. The gradual shift toward minimally invasive procedures is further expected to strengthen the region's growth trajectory.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Treatment StandardsGermany prioritizes clinically validated varicose veins treatment technologies that support accurate diagnosis and effective intervention. Healthcare providers in Germany increasingly adopt minimally invasive techniques while maintaining high procedural quality standards.
France 🇫🇷
Integrated Vascular CareFrance emphasizes coordinated vascular care supported by modern diagnostic capabilities and minimally invasive treatment options. Healthcare providers in France continue strengthening patient pathways that improve procedural efficiency and long-term vein health management.
Italy 🇮🇹
Specialist Clinic ExpansionItaly supports wider adoption of advanced varicose veins treatment through specialized vascular clinics and modern therapeutic techniques. Healthcare providers in Italy increasingly focus on efficient outpatient procedures that improve patient comfort and clinical outcomes.
Japan 🇯🇵
Outpatient Procedure AdoptionJapan continues expanding outpatient treatment options for varicose veins as healthcare providers seek efficient patient management. Hospitals and specialty clinics in Japan increasingly utilize minimally invasive procedures that reduce recovery time and improve treatment accessibility.
South Korea 🇰🇷
Advanced Vein ProceduresSouth Korea combines modern vascular treatment technologies with specialized clinical services for varicose veins management. Providers in South Korea increasingly adopt image-guided minimally invasive procedures that enhance treatment precision and patient experience.
United States 🇺🇸
Minimally Invasive CareThe U.S. varicose veins treatment market increasingly favors minimally invasive procedures supported by advanced imaging and outpatient care. Healthcare providers in the U.S. continue expanding access to endovenous therapies that improve patient convenience and recovery.
Segment Leadership and Growth Trends
Varicose Veins Treatment Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Injection Sclerotherapy (Largest Segment) vs Endovenous Ablation (Fastest-Growing Segment)
Injection sclerotherapy accounted for a 66.45% share in 2026, making it the leading treatment type in the varicose veins treatment market. Its established clinical use, minimally invasive nature, and suitability for treating affected veins contribute to its widespread adoption. The procedure can be performed without extensive surgical intervention, supporting patient preference for less invasive treatment approaches. Continued demand for effective management of varicose veins and established clinical familiarity with sclerotherapy reinforce its strong market position.
Endovenous ablation is experiencing faster adoption as treatment providers and patients increasingly favor minimally invasive approaches that can offer targeted vein treatment with reduced procedural burden. Advances in thermal ablation techniques and improved treatment precision have broadened its application in outpatient vascular care. The growing emphasis on shorter recovery, procedural convenience, and alternatives to conventional surgical intervention is supporting greater uptake of endovenous ablation.
End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
Hospitals held the largest share in 2026 in the varicose veins treatment market, reflecting their comprehensive vascular care capabilities and access to specialized clinical infrastructure. Hospitals are equipped to manage patients across varying levels of disease severity and can provide diagnostic assessment, procedural treatment, and follow-up care within an integrated setting. The availability of specialist expertise and established treatment facilities continues to support hospital-based utilization of varicose vein interventions.
Ambulatory surgical centers are gaining traction as minimally invasive vein treatments increasingly shift toward efficient outpatient settings. These facilities offer focused procedural environments that can support streamlined treatment workflows and patient convenience. Growing preference for less intensive care settings, combined with the suitability of minimally invasive vascular procedures for outpatient delivery, is encouraging greater adoption of varicose vein treatments in ambulatory surgical centers.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Endovenous Ablation, Injection Sclerotherapy, Surgical Ligation & Stripping | Injection Sclerotherapy | Endovenous Ablation |
| End-use | Hospitals, Ambulatory Surgical Centers, Specialty Clinics | Hospitals | Ambulatory Surgical Centers |
Competitive Landscape and Market Positioning
Leading companies in the varicose veins treatment market:
1. Medtronic plc (Ireland)
2. AngioDynamics Inc. (United States)
3. Lumenis Be Ltd. (Israel)
4. Alma Lasers Ltd. (Israel)
5. Sciton Inc. (United States)
6. Quanta System S.p.A. (Italy)
7. Dornier MedTech GmbH (Germany)
8. intros Medical Laser GmbH (Germany)
9. Theraclion SA (France)
10. Biolitec AG (Germany)
Minimally invasive medical procedures are reshaping treatment approaches for venous disorders. The varicose veins treatment market is evolving through improved laser and radiofrequency-based therapeutic methods. Continuous advancements in procedural precision are enhancing recovery outcomes and patient comfort.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| AngioDynamics Inc. (United States) | |||||||
| Lumenis Be Ltd. (Israel) | |||||||
| Alma Lasers Ltd. (Israel) | |||||||
| Sciton Inc. (United States) | |||||||
| Quanta System S.p.A. (Italy) | |||||||
| Dornier MedTech GmbH (Germany) | |||||||
| intros Medical Laser GmbH (Germany) | |||||||
| Theraclion SA (France) | |||||||
| Biolitec AG (Germany). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Avis Hospital | May-26 | Avis Hospital secured a $2.5 million investment from NABVENTURES, supported by Equity 360, to scale its specialized varicose veins treatment operations. This capital infusion is earmarked for expanding clinical infrastructure and enhancing access to advanced vascular care services specifically within rural regions of India, addressing a critical gap in service delivery. |
| Aakash Healthcare | May-26 | Aakash Healthcare partnered with Medtronic to launch a dedicated vein clinic in Dwarka, marking the first facility of its kind in North India. This collaboration integrates specialized clinical expertise with advanced medical technology to provide comprehensive treatment solutions, reflecting a strategic expansion in regional vascular care capacity and specialized medical service offerings. |
| WONTECH | May-26 | WONTECH established its Southeast Asia regional headquarters in Thailand, designated as WONTECH ASIA. This expansion serves to consolidate the company’s regional operations and provides a strategic hub for accelerating the deployment and support of its medical technology solutions, including those utilized in vascular and aesthetic treatment procedures throughout the region. |
| Koninklijke Philips N.V. | Jun-24 | Koninklijke Philips N.V. introduced the Duo stent, which received FDA approval for the treatment of patients suffering from chronic venous insufficiency (CVI) resulting in blood flow blockage. This product launch represents a material technological advancement in venous management, providing clinicians with a new interventional capability to address persistent venous obstruction and improve patient outcomes. |
| VVT Medical | Jan-24 | VVT Medical finalized a strategic distribution partnership with Methapharm Inc. to commercialize its ScleroSafe platform within the United States. This agreement effectively expands VVT Medical’s reach into the North American market, leveraging Methapharm’s distribution infrastructure to increase the availability of its non-invasive varicose vein treatment technology to clinical providers. |
| Theraclion | Jun-23 | Theraclion received U.S. FDA approval to initiate a pivotal clinical study evaluating the efficacy of its Sonovein system for treating primary insufficiency of the great saphenous veins. This development is a critical step in the regulatory and commercialization roadmap for its non-invasive therapeutic technology, aiming to validate its clinical utility in treating venous disease. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Varicose Veins Treatment Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Disease Severity | Mild Varicose Veins, Moderate Varicose Veins, Severe Varicose Veins |
| Reimbursement Type | Public Insurance, Private Insurance, Self-Pay |
| Patient Age Group | Adults Aged 18–44, Adults Aged 45–64, Adults Aged 65 and Above |
Varicose Veins Treatment Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Treatment Adoption Pathway Analysis |
|
| Minimally Invasive Procedure Opportunity Assessment |
|
| Clinical Innovation Pipeline Review |
|
Need a different cut of the data?
Request Custom ResearchHow much is the varicose veins treatment market worth?
What is the anticipated CAGR of the varicose veins treatment industry?
How are sedentary lifestyles and aging populations driving demand in the varicose veins treatment market?
How is the shift toward minimally invasive procedures and outpatient care shaping treatment adoption?
Why does Injection Sclerotherapy dominate the varicose veins treatment market?
Why is Endovenous Ablation the fastest-growing treatment type in varicose veins care?
Why does North America lead the varicose veins treatment market?
What is fueling varicose veins treatment market growth in Asia Pacific?
What are the key competitors in the varicose veins treatment landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization